Extract from the Register of European Patents

EP About this file: EP3386994

EP3386994 - 4,6-DI-(O-THIOPHOSPHATE)-INOSITOL-1,2,3,5-TETRA-O-SULFATE FOR C. DIFFICILE INFECTION [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  10.06.2022
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  08.11.2019
FormerGrant of patent is intended
Status updated on  27.06.2019
FormerExamination is in progress
Status updated on  16.03.2019
FormerRequest for examination was made
Status updated on  14.09.2018
FormerThe international publication has been made
Status updated on  16.06.2017
Formerunknown
Status updated on  16.12.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
ETH Zürich
Rämistrasse 101
8092 Zürich / CH
[2018/42]
Inventor(s)01 / IVARSSON, Mattias
Josefstrasse 17
8005 Zürich / CH
02 / LEROUX, Jean-Christophe
In der Sommerau 8
8053 Zürich / CH
03 / CASTAGNER, Bastien
4519 rue de Mentana
Montreal Québec H2J 387 / CA
 [2018/42]
Representative(s)Schulz Junghans Patentanwälte PartGmbB
Großbeerenstraße 71
10963 Berlin / DE
[2018/42]
Application number, filing date16808705.412.12.2016
[2018/42]
WO2016EP80545
Priority number, dateEP2015019968111.12.2015         Original published format: EP 15199681
EP2016016430007.04.2016         Original published format: EP 16164300
[2018/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017098033
Date:15.06.2017
Language:EN
[2017/24]
Type: A1 Application with search report 
No.:EP3386994
Date:17.10.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 15.06.2017 takes the place of the publication of the European patent application.
[2018/42]
Type: B1 Patent specification 
No.:EP3386994
Date:11.12.2019
Language:EN
[2019/50]
Search report(s)International search report - published on:EP15.06.2017
ClassificationIPC:C07F9/177, A61K31/6615, A61P31/04
[2018/42]
CPC:
C07F9/177 (EP,US); A61P31/04 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/42]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:4,6-DI-(O-THIOPHOSPHAT)-INOSITOL-1,2,3,5-TETRA-O-SULFAT FÜR INFEKTIONEN MIT C. DIFFICILE[2018/42]
English:4,6-DI-(O-THIOPHOSPHATE)-INOSITOL-1,2,3,5-TETRA-O-SULFATE FOR C. DIFFICILE INFECTION[2018/42]
French:4,6-DI- (O-THIOPHOSPHATE) -INOSITOL-1,2,3,5-TETRA-O-SULFATE POUR INFECTION C. DIFFICILE[2019/27]
Former [2018/42]4,6-DI-(O-THIOPHOSPHATE)-INOSITOL-1,2,3,5-TÉTRA-O-SULFATE POUR UNE INFECTION À C DIFFICILE
Entry into regional phase25.06.2018National basic fee paid 
25.06.2018Designation fee(s) paid 
25.06.2018Examination fee paid 
Examination procedure25.06.2018Examination requested  [2018/42]
25.06.2018Date on which the examining division has become responsible
24.01.2019Amendment by applicant (claims and/or description)
20.03.2019Despatch of a communication from the examining division (Time limit: M02)
12.04.2019Reply to a communication from the examining division
28.06.2019Communication of intention to grant the patent
01.11.2019Fee for grant paid
01.11.2019Fee for publishing/printing paid
01.11.2019Receipt of the translation of the claim(s)
Opposition(s)Opponent(s)01  05.08.2020   
HGF Limited
1 City Walk
Leeds Yorkshire LS11 9DX / GB
Opponent's representative
HGF
HGF Limited
4th Floor, 1 City Square
Leeds LS1 2ES / GB
 [N/P]
Former [2020/38]
Opponent(s)01  05.08.2020   
HGF Limited
1 City Walk
Leeds Yorkshire LS11 9DX / GB
Opponent's representative
HGF
1 City Walk
Leeds LS11 9DX / GB
01.10.2020Invitation to proprietor to file observations on the notice of opposition
11.11.2020Legal effect of rejection of opposition [2022/28]
11.02.2021Reply of patent proprietor to notice(s) of opposition
11.11.2021Date of oral proceedings
22.02.2022Despatch of minutes of oral proceedings
22.02.2022Date of despatch of rejection of opposition
Fees paidRenewal fee
21.12.2018Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.12.2016
AL11.12.2019
AT11.12.2019
CY11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
MK11.12.2019
MT11.12.2019
RO11.12.2019
RS11.12.2019
SI11.12.2019
SK11.12.2019
SM11.12.2019
TR11.12.2019
IE12.12.2019
LU12.12.2019
BE31.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
[2022/32]
Former [2022/27]HU12.12.2016
AL11.12.2019
AT11.12.2019
CY11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
MT11.12.2019
RO11.12.2019
RS11.12.2019
SI11.12.2019
SK11.12.2019
SM11.12.2019
TR11.12.2019
IE12.12.2019
LU12.12.2019
BE31.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2021/34]HU12.12.2016
AL11.12.2019
AT11.12.2019
CY11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
MT11.12.2019
RO11.12.2019
RS11.12.2019
SI11.12.2019
SK11.12.2019
SM11.12.2019
IE12.12.2019
LU12.12.2019
BE31.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2021/32]HU12.12.2016
AL11.12.2019
AT11.12.2019
CY11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
RO11.12.2019
RS11.12.2019
SI11.12.2019
SK11.12.2019
SM11.12.2019
IE12.12.2019
LU12.12.2019
BE31.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2021/26]AL11.12.2019
AT11.12.2019
CY11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
RO11.12.2019
RS11.12.2019
SI11.12.2019
SK11.12.2019
SM11.12.2019
IE12.12.2019
LU12.12.2019
BE31.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2020/51]AL11.12.2019
AT11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
RO11.12.2019
RS11.12.2019
SI11.12.2019
SK11.12.2019
SM11.12.2019
IE12.12.2019
LU12.12.2019
BE31.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2020/46]AL11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
RO11.12.2019
RS11.12.2019
SK11.12.2019
SM11.12.2019
IE12.12.2019
LU12.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2020/45]AL11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
MC11.12.2019
RO11.12.2019
RS11.12.2019
SK11.12.2019
SM11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2020/40]AL11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
RO11.12.2019
RS11.12.2019
SK11.12.2019
SM11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
IS11.04.2020
PT06.05.2020
Former [2020/37]AL11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
RO11.12.2019
RS11.12.2019
SK11.12.2019
SM11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
PT06.05.2020
Former [2020/36]AL11.12.2019
CZ11.12.2019
EE11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
RO11.12.2019
RS11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
PT06.05.2020
Former [2020/35]AL11.12.2019
CZ11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
RO11.12.2019
RS11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
Former [2020/32]AL11.12.2019
FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
RS11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
Former [2020/25]FI11.12.2019
HR11.12.2019
LT11.12.2019
LV11.12.2019
RS11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
Former [2020/23]FI11.12.2019
LT11.12.2019
LV11.12.2019
BG11.03.2020
NO11.03.2020
GR12.03.2020
Former [2020/22]FI11.12.2019
LT11.12.2019
BG11.03.2020
NO11.03.2020
Former [2020/21]NO11.03.2020
Cited inInternational search[AD] WO2013045107  (ETH ZUERICH et al.)
 [A]   ESTELLE DURANTIE ET AL: "New Paradigms for the Chiral Synthesis of Inositol Phosphates", CHEMBIOCHEM - A EUROPEAN JOURNAL OF CHEMICAL BIOLOGY., vol. 16, no. 7, 12 March 2015 (2015-03-12), DE, pages 1030 - 1032, XP055289967, ISSN: 1439-4227, DOI: 10.1002/cbic.201500071

DOI:   http://dx.doi.org/10.1002/cbic.201500071
 [A]   E DURANTIE: "Chemical Synthesis of Biomolecules Analogs: Inositol Phosphate/Sulfate Hybrids And Fluorinated Carbohydrates", DISS. ETH NO. 22532, 1 January 2015 (2015-01-01), ETH Zrich, pages 1 - 84, XP055333064
ExaminationUS9200015
 EP0269105
   THOMAS S. ELLIOTT ET AL: "The use of phosphate bioisosteres in medicinal chemistry and chemical biology", MEDCHEMCOMM, vol. 3, no. 7, 1 January 2012 (2012-01-01), United Kingdom, pages 735, XP055569563, ISSN: 2040-2503, DOI: 10.1039/c2md20079a

DOI:   http://dx.doi.org/10.1039/c2md20079a
   M R HAMBLIN ET AL: "myo -Inositol phosphorothioates, phosphatase-resistant analogues of myo -inositol phosphates. Synthesis of dl- myo -inositol 1,4-bisphosphate and dl- myo -inositol 1,4-bisphosphorothioate", BIOCHEMICAL JOURNAL, vol. 246, no. 3, 15 September 1987 (1987-09-15), GB, pages 771 - 774, XP055569564, ISSN: 0264-6021, DOI: 10.1042/bj2460771

DOI:   http://dx.doi.org/10.1042/bj2460771
by applicantWO2013045107
   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 127, 2005, pages 5288
   OHNISHI., ANA/. BIOCHEM., vol. 85, 1978, pages 165
   PROTEOMICS, vol. 1, 2001, pages 1359
OppositionWO2013045107
 WO2012138963
   THOMAS S. ELLIOTT, AINE SLOWEY, YULIN YE, STUART J. CONWAY: "The use of phosphate bioisosteres in medicinal chemistry and chemical biology", MEDCHEMCOMM, ROYAL SOCIETY OF CHEMISTRY, UNITED KINGDOM, vol. 3, no. 7, 1 January 2012 (2012-01-01), United Kingdom, pages 735 - 751, XP055569563, ISSN: 2040-2503, DOI: 10.1039/c2md20079a

DOI:   http://dx.doi.org/10.1039/c2md20079a
   E DURANTIE: "Chemical Synthesis of Biomolecules Analogs: Inositol Phosphate/Sulfate Hybrids And Fluorinated Carbohydrates", DISS. ETH NO. 22532, ETH ZRICH, ETH ZRICH, 1 January 2015 (2015-01-01), ETH Zrich, pages 1 - 84, XP055333064
   M R HAMBLIN, J S FLORA, B V L POTTER: "myo -Inositol phosphorothioates, phosphatase-resistant analogues of myo -inositol phosphates. Synthesis of dl- myo -inositol 1,4-bisphosphate and dl- myo -inositol 1,4-bisphosphorothioate", BIOCHEMICAL JOURNAL, PUBLISHED BY PORTLAND PRESS ON BEHALF OF THE BIOCHEMICAL SOCIETY., GB, vol. 246, no. 3, 15 September 1987 (1987-09-15), GB, pages 771 - 774, XP055569564, ISSN: 0264-6021, DOI: 10.1042/bj2460771

DOI:   http://dx.doi.org/10.1042/bj2460771
   COOKE ALLAN M, ET AL: "myo-lnositol 1,4,5-Trisphosphorothioate: A Novel Analogue of a Biological Second Messenger", J. CHEM. SOC., CHEM. COMMUN, 1 January 1987 (1987-01-01), pages 1525 - 1526, XP055815959, Retrieved from the Internet [retrieved on 20210621]
   SMITH S. W.: "Chiral Toxicology: It's the Same Thing...Only Different", TOXICOLOGICAL SCIENCES, vol. 110, no. 1, 2009, pages 4 - 30, XP055172718, DOI: 10.1093/toxsci/kfp097

DOI:   http://dx.doi.org/10.1093/toxsci/kfp097
   COOKE A. M.: "Synthesis and Biology of Inositol Phosphates and Thiophosphates", PHD THESIS, 1991, pages 1 - 203
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.